Study explores potency of antibodies to combat HIV infection
Thursday, September 15, 2016 - 19:02
in Health & Medicine
A clinical trial underway – known as the AMP study (for Antibody Meditated Prevention) – will determine whether infusing an experimental antibody (VRC01) into HIV-negative men and transgender individuals who have sex with men, will prevent the acquisition of HIV.